Corvus Pharmaceuticals Inc buy Barclays PLC
Start price
20.01.26
/
50%
€18.30
Target price
20.01.27
-
Performance (%)
-34.97%
Price
11.08.26
?
Summary
This prediction is currently active. Massive losses of -34.97% have been the result for the BUY prediction by Barclays_PLC. This prediction currently runs until 20.01.27. The prediction end date can be changed by Barclays_PLC at any time. Barclays_PLC has 50% into this predictionPerformance without dividends (%)
| Name | 1w | 1m |
|---|---|---|
| Corvus Pharmaceuticals Inc | 4.393% | 4.393% |
| iShares Core DAX® | 1.001% | 4.831% |
| iShares Nasdaq 100 | 2.702% | -1.720% |
| iShares Nikkei 225® | 3.519% | -3.506% |
| iShares S&P 500 | 1.766% | 1.273% |
Comments by Barclays_PLC for this prediction
In the thread Corvus Pharmaceuticals Inc diskutieren
Corvus Pharmaceuticals (NASDAQ:CRVS) had its "overweight" rating reaffirmed by analysts at Barclays PLC.
Ratings data for CRVS provided by MarketBeat